Charles River Laboratories
519 hedge funds and large institutions have $7.73B invested in Charles River Laboratories in 2025 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 174 increasing their positions, 201 reducing their positions, and 128 closing their positions.
1% more call options, than puts
Call options by funds: $219M | Put options by funds: $217M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.84% less ownership
Funds ownership: 104.46% → 103.62% (-0.84%)
4% less capital invested
Capital invested by funds: $8.03B → $7.73B (-$304M)
7% less funds holding
Funds holding: 561 → 519 (-42)
13% less repeat investments, than reductions
Existing positions increased: 174 | Existing positions reduced: 201
29% less first-time investments, than exits
New positions opened: 91 | Existing positions closed: 128
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Harris Associates
Chicago,
Illinois
|
+$155M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$129M |
| 3 |
D.E. Shaw & Co
New York
|
+$80.9M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$68.9M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$59.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$260M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$221M |
| 3 |
IC
Impactive Capital
New York City,
New York
|
-$182M |
| 4 |
DCP
D1 Capital Partners
New York
|
-$117M |
| 5 |
Goldman Sachs
New York
|
-$82.5M |
CRL Hedge Fund Activity: Q2 2025 in Review
519 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2025, worth a combined $7.73B — down 3.8% from $8.03B a quarter earlier.
Sellers outnumbered buyers: 128 funds closed out of CRL and 91 opened new positions — a net loss of 37 holders — while 201 trimmed existing stakes and 174 added.
The largest buyer was Harris Associates, opening a new position worth an estimated $155M. The largest seller was Kayne Anderson Rudnick Investment Management, cutting an estimated $260M.
- 519 institutional investors held Charles River Laboratories (CRL) as of Q2 2025, down from 561 in Q1 2025.
- Funds reported $7.73B of Charles River Laboratories stock for Q2 2025, down 3.8% quarter-over-quarter.
- 91 funds opened new Charles River Laboratories positions in Q2 2025 and 128 closed out, a net change of -37 holders.
- The largest Charles River Laboratories buyer in Q2 2025 was Harris Associates, an estimated $155M added.
- The largest Charles River Laboratories seller in Q2 2025 was Kayne Anderson Rudnick Investment Management, an estimated $260M sold.
Based on aggregated 13F filings for Q2 2025.